FDA's Overreach on Compounded Peptides FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures Pittsburgh Post Gazette The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and Is BPC 157 Legal? Understanding Its Status and Implications The Pharmacology of Longevity: Peptide Edition (Part 1) of the Federal Food, Drug, and Cosmetic Act (FDCA).*